Request Your Free Trend Report Now:

"Inside the development of cell and gene therapies"

More than 25 cell and gene therapy products have been approved by the FDA, and this burgeoning class of treatments is experiencing its own explosive growth.

As more of these potentially curative therapies reach patients, the industry continues to experiment with solutions to grapple with growing pains.

INCLUDED IN THIS TRENDLINE

• Kite’s next-gen CAR-T aims include quicker production and more disease targets
• Astellas’ science chief on the leap into new technologies
• Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health

Offered Free by: PharmaVoice and Quest Diagnostics
See All Resources from: PharmaVoice and Quest Diagnostics